| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.4M | +71.0% |
| Cost of Revenue | $6.6M | +138.6% |
| Gross Profit | $7.8M | +37.8% |
| R&D Expense | $174K | +295.5% |
| SG&A Expense | $7.5M | +3.4% |
| Operating Income | -$14.4M | -62.7% |
| Pre-tax Income | -$10.6M | -82.1% |
| Income Tax | $0 | — |
| Net Income | -$10.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | -28.5% |
| Inventory | $3.4M | +6.7% |
| Current Assets | $11.3M | -14.0% |
| Total Assets | $16.4M | -31.6% |
| Current Liabilities | $4.3M | +23.7% |
| Total Liabilities | $5.8M | -57.7% |
| Stockholders' Equity | $10.6M | +3.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.7M | +27.6% |
| Capital Expenditures | $112K | +115.4% |
| Investing Cash Flow | -$112K | +99.1% |
| Financing Cash Flow | $4.6M | -72.4% |
| Free Cash Flow | -$6.8M | +26.8% |
| -82.1% |
| EPS (Basic) | -$10.10 | -6633.3% |